Skip to content
Save up to 80% on your medications — Fast delivery
Arjuna
Guaranteed quality
Discreet shipping
Returns

Arjuna

4 customer reviews
Delivery: 4–7 days
Secure payment methods
24/7 Support
Active ingredient: Terminalia arjuna
Package Per unit Price
SSL Secure
Certified pharmacy
Money-back guarantee

Arjuna is an oral herbal tablet made from Terminalia arjuna. It is for adults seeking added support for heart health and blood pressure regulation. Its key benefit is supporting coronary circulation and antioxidant protection for the heart muscle.

What is it?

Arjuna is a herb used in traditional Ayurvedic practice for cardiovascular support, and its scientific name is Terminalia arjuna. In day-to-day pharmacy counselling, people usually choose Arjuna for “heart support” goals: circulation comfort, endurance, and helping keep blood pressure regulation on track when combined with lifestyle measures.

Arjuna is used for:

  • Heart health support, including comfort during exertion and general cardiac wellness
  • Circulation support, with a focus on coronary blood flow
  • Blood pressure regulation support for people already working on diet, weight, sleep, and stress

One limitation to know upfront: Arjuna is not a fast “rescue” option for chest pain or hypertensive urgency; it is used as a steady, supportive supplement, not emergency care.

If you are using Arjuna to support blood pressure, take home readings consistently (same arm, same time window daily). Random checks can look “worse” even when your trend is improving.

Composition

Active ingredient: Terminalia arjuna (arjuna) bark extract in tablets/capsules. Plant constituents typically include polyphenols (flavonoids, tannins), triterpenoids (e.g., arjunic/arjunolic acids), and minerals; excipients vary by manufacturer.

How to use?

Used as an oral herbal supplement to support normal cardiovascular function, including healthy circulation and antioxidant protection of blood vessels. It may be chosen as part of a wellness regimen for people seeking support for heart endurance and general vascular tone alongside diet and lifestyle measures.

How does it work?

  • Route: oral (swallow pills with water)
  • Dose: 500 mg per dose
  • Frequency: 2 times/day
  • Timing: after meals, morning and evening
  • Duration: 8–12 weeks, then reassess need; courses may be repeated after a 2–4 week break

Indications

Arjuna is used for:

  • Heart health support, including comfort during exertion and general cardiac wellness
  • Circulation support, with a focus on coronary blood flow
  • Blood pressure regulation support for people already working on diet, weight, sleep, and stress

Comparison

Arjuna sits in a “traditional heart-tonic herb” niche, which is different from fibre-based lipid support or omega-fatty-acid-focused products. The main advantage is its long Ayurvedic history for cardiac wellness; the main drawback is that the evidence base is smaller and less standardised than for prescription cardiovascular medicines.

Option (category) Primary focus Common downsides
Arjuna (Terminalia arjuna) Heart comfort, circulation support, “Arjuna for Heart and Blood Pressure” routines GI upset, dizziness at higher doses
Omega‑3 fatty acids (EPA/DHA) Triglyceride support and anti-inflammatory dietary support Fishy aftertaste, reflux; higher doses may affect bleeding tendency
Soluble fibre (psyllium, beta‑glucan) LDL support via reduced cholesterol absorption Bloating/gas; can affect absorption of other medicines if taken together

If you want a supplement that “feels” immediate, fibre or omega-3 often gives a clearer day-to-day signal (bowel changes, reflux changes). If you want a heart-focused Ayurvedic adjunct, Arjuna is the classic pick.

Contraindications

  • Hypersensitivity/allergy to Terminalia arjuna (Arjun) or any component of Arjuna
  • Age under 14 years

Not recommended for

Arjuna may not be a good fit if you are pregnant or breastfeeding, or if you have diabetes or hypertension and already take medicines for these conditions, because extra monitoring may be needed and additive blood-pressure lowering can cause light-headedness in some people.

Side effects

Most people tolerate Arjuna well at standard doses, yet side effects do happen. The most reported issues are digestive.

Possible side effects:

  • Abdominal pain, nausea, gas, diarrhoea
  • Skin rash in sensitive individuals
  • At higher doses: drowsiness, dizziness, confusion

Serious signals are rare but should be taken seriously if they occur. If you develop signs suggestive of liver intolerance (persistent nausea, unusual fatigue, dark urine, yellowing of the eyes), stop Arjuna and seek medical assessment promptly.

If you drive long distances for work, test your first few doses on a day off. Drowsiness is uncommon, yet it is predictable when it happens.

Common mistakes

People usually run into problems for avoidable reasons.

  • Taking it on an empty stomach and then blaming the product for nausea.
  • Chasing fast results and increasing the dose early, which raises the chance of dizziness or gut upset.
  • Mixing multiple “heart supplements” at once, then not knowing what caused the headache, reflux, or loose stools.
  • Stopping prescribed heart or blood pressure medicines because they “feel fine” after starting Arjuna; this is a risky pattern I have seen more than once.
  • Ignoring blood sugar patterns in diabetes; some people focus on BP and forget that diet changes plus supplements can shift appetite and glucose readings.

Sleep matters.

Hydration matters too.

Frequently asked questions

Most people who feel a difference describe it after 2–4 weeks of consistent use, and sometimes longer for lipid-related goals. The change is usually subtle: steadier exercise tolerance, fewer “heavy chest” sensations during exertion, or improved BP trend stability. This timing fits the general pattern described for herbal cardiovascular supports in WHO monographs, where effects are assessed over weeks, not days [3]. Date: 2026.

It can be combined in some cases, yet additive lowering can cause light-headedness, especially during the first week or after dose changes. Watch for dizziness when standing, unusual fatigue, or headaches that correlate with low readings. People on multiple antihypertensives should monitor home BP more closely when adding any supplement, a point echoed in EMA-style safety communication principles around polypharmacy vigilance [4]. Date: 2026.

Arjuna is sometimes used by people with diabetes as part of a heart-health routine, since cardiovascular risk is higher in diabetes. The key is consistency in glucose monitoring when you change routines, because appetite, meal timing, and activity often shift at the same time you introduce supplements. If you use insulin or sulfonylureas, unexpected low readings are the main practical concern to catch early. Date: 2026, MOHAP chronic disease guidance emphasises planned monitoring when changing health routines.

Many users take it for months, reassessing based on tolerability and objective markers like BP averages and lipid labs. If you get recurrent diarrhoea, reflux, or persistent drowsiness, that is a sign to stop and reassess rather than “pushing through.” Long-term supplement routines make the most sense when they are anchored to measurable targets, a point aligned with WHO approaches to self-care interventions that still emphasise monitoring. Date: 2026.

Avoid starting Arjuna on the same week you introduce two or three other new supplements, since side effects become hard to attribute. Avoid doubling doses after a missed dose, because that is when dizziness and confusion complaints show up. If you have a scheduled fasting blood test, keep your morning routine consistent so the results are comparable over time. Date: 2026, general EMA pharmacovigilance principles support minimising confounders when assessing tolerability.

No. Arjuna is used as supportive care for wellness goals, while statins and other cardiovascular medicines are prescribed to reduce hard outcomes like heart attack and stroke risk in defined patient groups. People with established cardiovascular disease should keep guideline-based therapy as the foundation; adding Arjuna is a separate choice that should not change prescribed dosing. Date: 2026, WHO cardiovascular risk management publications emphasise evidence-based therapy for high-risk patients [5].

Front view Front view
Side view Side view
Back view Back view

Your order will be securely packed and shipped within 24 hours. This is exactly what your package will look like (images of an actual item sent). It has the size and look of a regular private letter (9.4x4.3x0.3 in. or 24x11x0.7 cm) and its contents cannot be seen.

Arjuna — Comparison with alternatives

Reviews and Experiences

K
Khalid, 46
Abu Dhabi
6 weeks
Verified
I used it after meals and tracked my BP at home. Readings were a bit steadier by week three, and I felt less winded on stairs. No side effects except mild gas the first few days.
12/02/2026
M
Mariam, 39
Dubai
10 days
Verified
I started at the higher dose and felt sleepy in the afternoons, plus loose stools. I reduced to 1 tablet twice daily after meals and the stomach issue settled, but I realised I need to go slower.
08/01/2026
S
Saeed, 52
Sharjah
1 month
Verified
Cholesterol was my main concern. I did not feel a big day-to-day change, but I liked that it did not upset my stomach. I planned to judge it only after my next lab check.
21/03/2026
N
Noura, 34
Al Ain
8 weeks
Verified
I was doing walking plus diet changes and added Arjuna to support circulation. The biggest change was fewer headaches linked to stress days, though I can’t say what came from what. I kept it because it was easy to tolerate.
15/04/2026

Sources

  1. European Society of Cardiology (2025). ESC Guidelines for the Management of Chronic Coronary Syndromes.
  2. MOHAP (Ministry of Health and Prevention) (2026). Guidance on Safe Use of Health Supplements for the Public and High‑Risk Groups.
  3. World Health Organization (WHO) (2026). WHO Monographs on Selected Medicinal Plants: Quality, Safety and Efficacy Framework.
  4. European Medicines Agency (EMA) (2026). Guideline on Good Pharmacovigilance Practices: Identifying and Minimising Risk from Interactions and Polypharmacy.
  5. World Health Organization (WHO) (2025). Cardiovascular Disease Risk Management and Secondary Prevention: Evidence-Based Recommendations.
Get our free app Shop faster and track your orders 4.1 · 1,245 reviews Install